证券代码：600378 证券简称：昊华科技 公告编号：临2025-082 昊华化工科技集团股份有限公司 关于新开立募集资金专户并签订募集资金专户存储六方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 经中国证券监督管理委员会证监许可〔2024〕964号文注册批复，昊华化工科技集团股份有限公司（以 下简称"公司"）向特定对象发行人民币普通股（A股）股票181,451,612股，每股发行价格为人民币24.80 元，募集资金总额为人民币4,499,999,977.60元，扣除不含增值税的发行费用人民币3,050,416.26元后， 募集资金净额为人民币4,496,949,561.34元。2024年12月25日，独立财务顾问（牵头主承销商）中信证券 股份有限公司（以下简称"中信证券"）已将上述募集资金总额扣除承销费（含增值税）后的余款划转至 公司指定募集资金专用账户。天健会计师事务所（特殊普通合伙）对本次募集资金到位情况进行了审 验，并出具了《验资报告》（天健验〔2024〕530号）、《验证报告》 ...

Core Viewpoint - The company is undergoing a restructuring process by merging its wholly-owned subsidiaries to enhance operational efficiency and optimize its fluorochemical business structure [2][7]. Group 1: Merger Details - The company’s wholly-owned subsidiary, Hunan Zhonglan New Materials Technology Co., Ltd., will absorb another wholly-owned subsidiary, Chenzhou Zhonghua Fluorine Source New Materials Co., Ltd. [2][7] - After the merger, Hunan Zhonglan will inherit all assets, debts, and rights of Chenzhou Fluorine Source, which will be deregistered [2][3]. Group 2: Fundraising and Investment Projects - The company raised a total of RMB 4,499,999,977.60 through the issuance of 181,451,612 shares at RMB 24.80 per share, with a net amount of RMB 4,496,949,561.34 after deducting issuance costs [3][4]. - The fundraising will be used for projects including the expansion of a 3,000 tons/year CTFE and 10,000 tons/year R113a co-production project, with the implementation subject changing from Chenzhou Fluorine Source to Hunan Zhonglan [6][7]. Group 3: Approval Process - The board of directors and the supervisory board approved the merger and the change of the investment project implementation subject during meetings held on August 28, 2025 [8][10]. - The independent financial advisor, CITIC Securities, confirmed that the merger and project changes complied with relevant regulations and did not alter the intended use of the raised funds [9][10].

Core Viewpoint - The company is undergoing a restructuring process by merging its wholly-owned subsidiaries to enhance operational efficiency and optimize its corporate structure, specifically in the fluorochemical business sector [1][5]. Group 1: Merger Details - The company’s wholly-owned subsidiary, Hunan Zhonglan New Materials Technology Co., Ltd., will absorb another subsidiary, Chenzhou Zhonghua Fluorine Source New Materials Co., Ltd., with the latter's legal entity being dissolved post-merger [1][5]. - The merger is aimed at improving the management efficiency and operational focus of the company, aligning with national and local reforms for state-owned enterprises [5][6]. Group 2: Fundraising and Investment Projects - The company raised approximately RMB 4.5 billion through the issuance of 181,451,612 shares at a price of RMB 24.80 per share, with net proceeds amounting to RMB 4,496,949,561.34 after deducting issuance costs [2][4]. - The investment project "Expansion of 3,000 tons/year CTFE and 10,000 tons/year R113a co-production project" will now be implemented by Hunan Zhonglan New Materials following the merger [5][6]. Group 3: Approval Process - The board of directors and the supervisory board approved the merger and the change of the investment project’s implementation entity during meetings held on August 28, 2025 [6][8]. - The independent financial advisor, CITIC Securities, confirmed that the merger and the change of the investment project’s implementation entity comply with relevant regulations and do not alter the intended use of the raised funds [7][8].